PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Nov-2019 Jazz Pharmaceuticals Announces Third Quarter 2019 Financial Results Jazz Pharmaceuticals plc
05-Nov-2019 Rigel Announces Third Quarter 2019 Financial Results Rigel Pharmaceuticals, Inc.
05-Nov-2019 Portola Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update Portola Pharmaceuticals, Inc.®
05-Nov-2019 Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome Masters Speciality Pharma
05-Nov-2019 OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer Orion Biotechnology Canada
05-Nov-2019 SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announced & Brochure Released SMi Group
05-Nov-2019 PureTech Announces Presentation of New Data Supporting Wholly Owned Immuno-Oncology Programmes LYT-200 (anti-galectin-9) and LYT-210 (anti-delta-1) PureTech Health plc
05-Nov-2019 Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector Kayentis
05-Nov-2019 PAION AG INVITES TO SHAREHOLDER EVENING PAION AG
05-Nov-2019 MediClin: Group sales plus 4 % compared to previous year's period MediClin AG
05-Nov-2019 ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer ADC Therapeutics SA
05-Nov-2019 Cytel acquires MTEK Sciences, further expanding its advanced real-world analytics capabilities Cytel
05-Nov-2019 EVOTEC SE TO ANNOUNCE RESULTS FOR THE FIRST NINE MONTHS 2019 ON 12 NOVEMBER 2019 Evotec SE
05-Nov-2019 Sygnature Discovery invests in high-throughput screening capability Sygnature Discovery
05-Nov-2019 SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases B3C newswire
05-Nov-2019 Mehiläinen Yhtiöt Oy Announces a Recommended Cash Tender Offer for all Shares in Pihlajalinna Plc Mehiläinen Oy
05-Nov-2019 Sacro Cuore-Don Calabria Cancer Care Center Treats its First Patient With Elekta Unity MR-Linac Elekta
05-Nov-2019 Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 Samsung BioLogics
04-Nov-2019 Epigenomics AG: No operational reasons for sharp decline in share price Epigenomics AG
04-Nov-2019 Exclusive interview from conference speaker John Lisman released ahead of Parallel Trade 2020 SMi Group